Details of the Drug Reposition

General Information of This Drug (ID: DMUICJD)

Drug Name
SAR-156597   DMUICJD
Synonyms IL-4/IL-13-targeting bispecific mAb (idiopathic pulmonary fibrosis), sanofi-aventis
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Systemic sclerosis DISF44L6 4A42 Phase 2 [1]
Idiopathic pulmonary fibrosis DISZGA69 CB03.4 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02345070) Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis